Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland - PubMed (original) (raw)

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

J L Hayward et al. Cancer. 1977 Mar.

No abstract available

PubMed Disclaimer

Similar articles

• Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland.
  Hayward JL, Rubens RD, Carbone PP, Heuson JC, Kumaoka S, Segaloff A. Hayward JL, et al. Eur J Cancer (1965). 1978 Nov;14(11):1291-2. doi: 10.1016/0014-2964(78)90238-4. Eur J Cancer (1965). 1978. PMID: 738335 No abstract available.
• [Project of a program for the estimation of efficacy of treatment of patients with far-advanced forms of breast cancer].
  [No authors listed] [No authors listed] Vopr Onkol. 1977;23(9):8-12. Vopr Onkol. 1977. PMID: 910430 Russian. No abstract available.
• Potential for cost economies in guiding therapy in patients with metastatic breast cancer.
  Robertson JF, Whynes DK, Dixon A, Blamey RW. Robertson JF, et al. Br J Cancer. 1995 Jul;72(1):174-7. doi: 10.1038/bjc.1995.297. Br J Cancer. 1995. PMID: 7599049 Free PMC article.
• Critical evaluation of methods of destroying the pituitary gland in the treatment of cancer.
  Escher F. Escher F. Aktuelle Probl Chir. 1970;14:757-84. Aktuelle Probl Chir. 1970. PMID: 4146445 Review. No abstract available.
• Principles of therapy in advanced breast cancer.
  Ingle JN. Ingle JN. Hematol Oncol Clin North Am. 1989 Dec;3(4):743-63. Hematol Oncol Clin North Am. 1989. PMID: 2481669 Review.

Cited by

• Thymidine kinase in breast cancer.
  Robertson JF, O'Neill KL, Thomas MW, McKenna PG, Blamey RW. Robertson JF, et al. Br J Cancer. 1990 Oct;62(4):663-7. doi: 10.1038/bjc.1990.352. Br J Cancer. 1990. PMID: 2223587 Free PMC article.
• Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy.
  Vincent MD, Powles TJ, Coombes RC, McElwain TJ. Vincent MD, et al. Cancer Chemother Pharmacol. 1988;21(3):255-60. doi: 10.1007/BF00262781. Cancer Chemother Pharmacol. 1988. PMID: 3282709
• [Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies].
  Wander HE, Blossey HC, Nagel GA, Emrich D. Wander HE, et al. Klin Wochenschr. 1985 Apr 1;63(7):312-8. doi: 10.1007/BF01731974. Klin Wochenschr. 1985. PMID: 2987601 Clinical Trial. German.
• Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.
  Forward DP, Cheung KL, Jackson L, Robertson JF. Forward DP, et al. Br J Cancer. 2004 Feb 9;90(3):590-4. doi: 10.1038/sj.bjc.6601557. Br J Cancer. 2004. PMID: 14760369 Free PMC article. Clinical Trial.
• Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer.
  Burcombe RJ, Makris A, Richman PI, Daley FM, Noble S, Pittam M, Wright D, Allen SA, Dove J, Wilson GD. Burcombe RJ, et al. Br J Cancer. 2005 Jan 17;92(1):147-55. doi: 10.1038/sj.bjc.6602256. Br J Cancer. 2005. PMID: 15611798 Free PMC article.

MeSH terms

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database